- CVS obesity drug deal puts Lilly on equal footing with Novo<figure><div><img src="https://imgproxy.divecdn.com/LUU4XfIR8eFQgmY5HrlCjsI3-Klo8riH1u1jZ_W_2D4/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9MaWxseV9PRkdfQm90dGxlX1RhYmxldF9HM…BioPharma Dive · 2mo ago↗ source
- ICON audit finds overstated revenue; Secretome and Psilera raise cash👀 ICON’s audit probe is complete: The investigation found that ICON’s revenue was overstated by $65.3 million in 2023 (about 0.8% of its total revenue that year) and by $92.7 million in 2024 (1.1%…Endpoints · 2mo ago↗ source
- #ASCO26: After leaving Legend, Frank Fan is ready to showcase his next projectIn 2022, Frank Fan moved more than 800 miles from Nanjing to Shenzhen, China, seeking a fresh start. He had abruptly left Legend Biotech, the CAR-T company he co-founded, just one month after the m…